|
Polmacoxib Impurity 20
|
|
1672668-30-2
|
|
Carenoprazan Impurity 3
|
奈玛特韦杂质34
|
2768834-00-8
|
|
Rasagiline Impurity 40
|
|
1631061-76-1
|
|
Polmacoxib Impurity 15
|
|
2826252-90-6
|
|
Vibegron Impurity 3
|
1-(N-tryptophan)-1-deoxyfructose
|
25020-15-9
|
|
Vecabrutinib
|
3-(哌啶-4-基)-3,4-二氢喹唑啉-2(1H)-酮
|
79098-75-2
|
|
Vecabrutinib Impurity 5
|
N-(4-(三氟甲氧基)苯基)哌啶-4-胺
|
681482-48-4
|
|
Phenylbutazone Impurity 24
|
OseltaMivir Acid PotassiuM Salt
|
1363339-68-7
|
|
Polmacoxib Impurity 3
|
替格瑞洛杂质8
|
378236-67-0
|
|
Polmacoxib
|
376608-67-2
|
376608-67-2
|
|
Emorfazone Impurity 11
|
|
107741-27-5
|
|
Polmacoxib Impurity 12
|
|
1672668-50-6
|
|
Vecabrutinib Impurity 6
|
3-(2-羟基乙基)-6,7-二甲氧基-1H-喹唑啉-2,4-二酮
|
110231-25-9
|
|
Vecabrutinib Impurity 7
|
3-乙基-6,7-二甲氧基-1H-喹唑啉-2,4-二酮
|
335417-99-7
|
|
Vibegron Impurity 2
|
MENAQUINONE 4 2,3-EPOXIDE
|
72908-86-2
|
|
Carenoprazan Impurity 5
|
苯锈啶
|
67306-00-7
|
|
Phenylbutazone Impurity 21
|
奥司他韦酸-D3
|
1242184-43-5
|
|
Phenylbutazone Impurity 32
|
氯唑苄星青霉素
|
23736-58-5
|
|
Vibegron Impurity 6
|
|
2370016-04-7
|
|
Polmacoxib Impurity 19
|
|
2826252-94-0
|
|
Polmacoxib Impurity 26
|
|
2370015-98-6
|
|
Vecabrutinib Impurity 8
|
3-(3-氯苯基)-6,7-二甲氧基-1H-喹唑啉-2,4-二酮
|
364748-38-9
|
|
Vecabrutinib Impurity 2
|
6-羟基-3,4-二氢喹唑啉-2(1H)-酮
|
948552-89-4
|
|
Phenylbutazone Impurity 31
|
氟氯西林杂质7
|
42947-70-6
|
|
Carenoprazan Impurity 2
|
2,2,3,3,4,4,5,5,6,6-decadeuterio-N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexane-1-carboxamide
|
1246815-53-1
|
|
Rasagiline Impurity 42
|
|
1030595-43-7
|
|
Carenoprazan Impurity 4
|
奈玛特韦杂质32
|
2768833-99-2
|
|
Polmacoxib Impurity 11
|
|
1672668-35-7
|
|
Polmacoxib Impurity 16
|
|
2826252-91-7
|
|
Phenylbutazone Impurity 14
|
N-DEFORMYL-N-PIVALOYL ORLISTAT
|
1356017-35-0
|
|
Phenylbutazone Impurity 22
|
5-(乙酰氨基)-4-氨基-3-(1-乙基丙氧基)-1-环己烯-1-羧酸
|
1391047-93-0
|
|
Polmacoxib Impurity 1
|
376608-68-3
|
376608-68-3
|
|
Emorfazone Impurity 2
|
Naftifine (Z)-Isomer
|
65473-08-7
|
|
Rasagiline Impurity 36
|
|
1360459-39-7
|
|
Rasagiline Impurity 38
|
|
1631061-74-9
|
|
Polmacoxib Impurity 13
|
|
2007088-16-4
|
|
Emorfazone Impurity 10
|
呋嘧醇
|
56425-91-3
|
|
Vecabrutinib Impurity 14
|
2,4-二羟基-6,7-二乙氧基喹唑啉
|
20197-80-2
|
|
Vecabrutinib Impurity 12
|
4-苯基-3,4-二氢喹唑啉-2(1H)-酮
|
107289-02-1
|
|
Rasagiline Impurity 41
|
4'-C-叠氮基-3'-脱氧-3'-氟胞苷
|
1145869-46-0
|
|
Phenylbutazone Impurity 18
|
N,N-DideMethylorphenadrine Hydrochloride
|
17752-32-8
|
|
Phenylbutazone Impurity 26
|
奥司他韦13CD3
|
1093851-61-6
|
|
Phenylbutazone Impurity 35
|
3,4-二氟肉桂酸
|
112897-97-9
|
|
Phenylbutazone Impurity 16
|
(R,S,S,S)-Orlistat Tetradecyl Ester
|
1356019-45-8
|
|
Polmacoxib Impurity 21
|
|
2365402-28-2
|
|
Vecabrutinib Impurity 23
|
四烯甲萘醌杂质2
|
70662-30-5
|
|
Vecabrutinib Impurity 22
|
脱氮黄素
|
26908-38-3
|
|
Polmacoxib Impurity 22
|
|
1672668-39-1
|
|
Vibegron Impurity 5
|
|
2883232-91-3
|
|
Vecabrutinib Impurity 9
|
3-(2-氯乙基)-6,7-二甲氧基-1H-喹唑啉-2,4-二酮
|
110231-26-0
|
|
Vecabrutinib Impurity 15
|
|
199186-62-4
|
|
Phenylbutazone Impurity 25
|
奥司他韦杂质
|
1415963-60-8
|
|
Carenoprazan Impurity 7
|
|
38394-98-8
|
|
Emorfazone Impurity 5
|
|
214542-41-3
|
|
Emorfazone Impurity 12
|
|
94361-21-4
|
|
Vibegron Impurity 4
|
阿哌沙班杂质93
|
40345-06-0
|
|
Ondansetron Impurity 12
|
|
123638-70-0
|
|
Polmacoxib Impurity 6
|
|
2007088-15-3
|
|
Vibegron Impurity 11
|
3-丁氧基-4-硝基苯甲酸
|
72101-53-2
|
|
Polmacoxib Impurity 17
|
|
2826252-92-8
|
|
Polmacoxib Impurity 24
|
|
2738682-45-4
|
|
Vecabrutinib Impurity 10
|
6-(difluoromethoxy)-1,2,3,4-tetrahydroquinoline
|
954264-62-1
|
|
Vecabrutinib Impurity 16
|
|
199188-80-2
|
|
Vecabrutinib Impurity 21
|
羟甲唑啉杂质3 盐酸盐
|
205035-03-6
|
|
Vecabrutinib Impurity 1
|
|
79098-88-7
|
|
Vecabrutinib Impurity 17
|
3,4-二氢-3-甲基-2(1H)-喹唑啉酮
|
24365-65-9
|
|
Vibegron Impurity 9
|
125602-69-9
|
125602-69-9
|
|
Osimertinib-13C,d3
|
奥斯替尼-13C,d3
|
2254100-49-5
|
|
Vecabrutinib Impurity 3
|
5-(三氟甲氧基)吲哚酮
|
403853-48-5
|
|
Rasagiline Impurity 43
|
|
1360459-02-4
|
|
Vecabrutinib Impurity 13
|
|
119198-23-1
|
|
Rasagiline Impurity 37
|
|
1360459-46-6
|
|
Polmacoxib Impurity 5
|
|
1672668-51-7
|
|
Rasagiline Impurity 39
|
|
1631061-75-0
|
|
Polmacoxib Impurity 14
|
|
2055231-72-4
|
|
Emorfazone Impurity 6
|
乌诺前列酮
|
120373-36-6
|
|
Phenylbutazone Impurity 15
|
N-DEFORMYL-N-BENZYLOXYCARBONYL ORLISTAT
|
108051-94-1
|
|
Phenylbutazone Impurity 5 Sulfate (Phenylbutazone EP Impurity E Sulfate)
|
AHLBNYSZXLDEJQ-HDVRVJOHSA-N
|
1356930-46-5
|
|
Emorfazone Impurity 3
|
1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol:hydrochloride
|
1164469-60-6
|
|
Emorfazone Impurity 8
|
(E)-N-[(4R,4aS,7S,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-yl]-3-(furan-3-yl)-N-methylprop-2-enamide
|
152658-36-1
|
|
Phenylbutazone Impurity 19
|
(R)-Orphenadrine Citrate
|
1202395-79-6
|
|
Polmacoxib Impurity 4
|
PT2977
|
1672668-24-4
|
|
Vibegron
|
维生素K2杂质05
|
110327-29-2
|
|
Vecabrutinib Impurity 18
|
|
17730-75-5
|
|
Polmacoxib Impurity 23
|
|
1672668-44-8
|
|
Vibegron Impurity 7
|
|
2370016-14-9
|
|
Vecabrutinib Impurity 4
|
8-(difluoromethoxy)-1,2,3,4-tetrahydroquinoline
|
953735-66-5
|
|
Phenylbutazone Impurity 23
|
(3S,4S,5R)-4-(乙酰氨基)-5-氨基-3-(1-乙基丙氧基)-1-环己烯-1-羧酸乙酯磷酸盐
|
1035895-89-6
|
|
Vecabrutinib Impurity 11
|
6,7-二甲氧基-3-甲基喹唑啉-2,4(1H,3H)-二酮
|
20197-88-0
|
|
Vibegron Impurity 1
|
四烯甲萘醌杂质3
|
55700-10-2
|
|
Carenoprazan Impurity 6
|
6-[3-[[1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl]amino]-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol
|
1246820-10-9
|
|
Carenoprazan Impurity 8
|
17Β-氰基-17Α-羟基雄甾-4-烯-3-酮
|
77881-13-1
|
|
Carenoprazan
|
|
2690342-18-6
|
|
Polmacoxib Impurity 18
|
|
2826252-93-9
|
|
Polmacoxib Impurity 25
|
|
2370102-07-9
|
|
Phenylbutazone Impurity 17
|
XMSSICJSZNPVFX-BMSJAHLVSA-N
|
1329647-21-3
|
|
Phenylbutazone Impurity 28
|
2-[4-[(E)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]ethanol
|
238089-02-6
|
|
Vibegron Impurity 8
|
|
210095-51-5
|
|
Esomeprazole Impurity 179
|
|
107711-02-4
|
|
Ondansetron Hydrochloride
|
|
96223-47-1
|